Addiction

• 

  Publication Venue For

  • The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study..  117:2438-2447. 2022
  • Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial..  117:444-456. 2022
  • Regulatory oversight of behavioral digital therapeutics for addiction treatment: A commentary on Khadjesari et al..  116:3287-3289. 2021
  • Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network..  116:1805-1816. 2021
  • Commentary on Winhusen et al. (2019): Substance use disorders, chronic diseases, and electronic health records-a paradigm for screening and intervention..  114:1471-1472. 2019
  • Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?.  114:1346-1353. 2019
  • Response to commentaries..  114:1357-1358. 2019
  • Why we work with the tobacco industry..  114:374-375. 2019
  • Precision medicine in addiction research: where has the time gone?.  112:2096-2097. 2017
  • Pre-exposure prophylaxis for people who inject drugs and their sex partners..  112:579-580. 2017
  • Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child..  111:2115-2128. 2016
  • Alcohol limits in older people..  107:1541-1543. 2012
  • Reductions in alcohol and cocaine use following a group coping intervention for HIV-positive adults with childhood sexual abuse histories..  105:1942-1951. 2010
  • The Demand for Alcohol, Tobacco, and Marijuana: International Evidence by S. Selvanathan and E.A. Selvanathan 2007
  • Cost-Benefit Analysis of Heroin Maintenance Treatment by Felix Gutzwiller and Thomas Steffen 2001